3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
46
Lung Neoplasms
28
Neoplasms
26
Colorectal Neoplasms
21
Prostatic Neoplasms
16
Uterine Cervical Neoplasms
9
Fatigue
9
Hematologic Neoplasms
8
Lymphoma
7
Hematopoietic and Lymphatic System Neoplasm
7
Anxiety Disorders
7
Papillomavirus Infections
6
Melanoma
6
Neoplasm Metastasis
5
Multiple Myeloma
5
Gastrointestinal Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Urinary Bladder Neoplasms
4
Skin Neoplasms
4
Ovarian Neoplasms
4
Obesity-Related Malignant Neoplasm
4
Obesity
4
Motor Activity
4
Hematopoietic and Lymphoid System Neoplasm
4
Head and Neck Neoplasms
4
Depression
4
Breast Carcinoma In Situ
4
Triple Negative Breast Neoplasms
3
Pancreatic Neoplasms
3
Leukemia, Myeloid, Acute
3
Interventions
Gemcitabine
15
Mitomycin
10
Docetaxel
7
BCG Vaccine
7
Cystoscopy
4
tislelizumab
3
durvalumab
3
Radiotherapy
3
Epirubicin
3
disitamab vedotin
2
avelumab
2
Hyaluronic Acid
2
tremelimumab
1
toripalimab
1
pemigatinib
1
pembrolizumab
1
monalizumab
1
lornoxicam
1
erdafitinib
1
enzalutamide
1
chondroitin sulfate, sodium hyaluronate drug combination
1
bicalutamide
1
VPM1002 recombinant BCG vaccine
1
Urine Specimen Collection
1
Ty21a typhoid vaccine
1
Transurethral Resection of Bladder
1
Therapeutics
1
Surveys and Questionnaires
1
Sugars
1
Saline Solution
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Non-Muscle Invasive Bladder Neoplasms
×
Educational Status
×
Clear all
NCT05154084
2023-11-14
RESECT
British Urology Researchers in Surgical Training
Completed
19,505 enrolled